Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?

Saved in:
Bibliographic Details
Title: Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Authors: Hentschel AE; Urology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van Rhijn BWG; Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: basvanrhijn@hotmail.com., Bründl J; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Compérat EM; Pathology, Tenon Hospital, AP-HP, UPMC Paris VI, Sorbonne University, Paris, France., Plass K; EAU Guidelines Office Board, European Association of Urology, Arnhem, the Netherlands., Rodríguez O; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Henríquez JDS; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Hernández V; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., de la Peña E; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Alemany I; Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Turturica D; Urology Clinic, Citta' della Salute e della Scienza, University of Studies of Torino, Torino, Italy., Pisano F; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Urology Clinic, Citta' della Salute e della Scienza, University of Studies of Torino, Torino, Italy., Soria F; Urology Clinic, Citta' della Salute e della Scienza, University of Studies of Torino, Torino, Italy., Čapoun O; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Bauerová L; Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Pešl M; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Bruins HM; Urology, Radboud University Medical Center, Nijmegen, the Netherlands., Runneboom W; Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Herdegen S; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Breyer J; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Brisuda A; Urology,Teaching Hospital Motol, Prague, Czech Republic., Scavarda-Lamberti A; Pathology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain., Calatrava A; Pathology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain., Rubio-Briones J; Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain., Seles M; Urology, Medical University of Graz, Graz, Austria., Mannweiler S; Pathology, Medical University of Graz, Graz, Austria., Bosschieter J; Urology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Kusuma VRM; Urology, Royal Surrey County Hospital-NHS Foundation Trust, Guildford, Surrey, United Kingdom., Ashabere D; Urology, Royal Surrey County Hospital-NHS Foundation Trust, Guildford, Surrey, United Kingdom., Huebner N; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Cotte J; Urology, Pitié Salpétrière Hospital, AP-HP, GRC n 5, ONCOTYPE-URO, Sorbonne University, Paris, France., Mertens LS; Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Cohen D; Urology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, United Kingdom., Lunelli L; Urology, Tenon Hospital, AP-HP, UPMC Paris VI, Sorbonne University, Paris, France., Cussenot O; Urology, Tenon Hospital, AP-HP, UPMC Paris VI, Sorbonne University, Paris, France., Sheikh SE; Pathology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, United Kingdom., Volanis D; Urology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, United Kingdom., Coté JF; Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France., Rouprêt M; Urology, Pitié Salpétrière Hospital, AP-HP, GRC n 5, ONCOTYPE-URO, Sorbonne University, Paris, France., Haitel A; Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Shariat SF; Urology,Teaching Hospital Motol, Prague, Czech Republic; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Mostafid AH; Urology, Royal Surrey County Hospital-NHS Foundation Trust, Guildford, Surrey, United Kingdom., Nieuwenhuijzen JA; Urology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Zigeuner R; Urology, Medical University of Graz, Graz, Austria., Dominguez-Escrig JL; Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain., Hacek J; Pathology, Teaching Hospital Motol, Prague, Czech Republic., Zlotta AR; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Burger M; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Evert M; Pathology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Hulsbergen-van de Kaa CA; Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., van der Heijden AG; Urology, Radboud University Medical Center, Nijmegen, the Netherlands., Kiemeney LALM; Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands., Soukup V; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Molinaro L; Pathology, Citta' della Salute e della Scienza, University of Studies of Torino, Torino, Italy., Gontero P; Urology Clinic, Citta' della Salute e della Scienza, University of Studies of Torino, Torino, Italy., Llorente C; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Algaba F; Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Palou J; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., N'Dow J; EAU Guidelines Office Board, European Association of Urology, Arnhem, the Netherlands., Babjuk M; Urology,Teaching Hospital Motol, Prague, Czech Republic; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., van der Kwast TH; Pathology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Sylvester RJ; EAU Guidelines Office Board, European Association of Urology, Arnhem, the Netherlands.
Source: Urologic oncology [Urol Oncol] 2020 May; Vol. 38 (5), pp. 440-448. Date of Electronic Publication: 2019 Nov 05.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2496
DOI:10.1016/j.urolonc.2019.10.002